욕창 치료 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 임상 중증도별, 용도별, 지역별 및 부문별 예측(2026-2033년)

Pressure Ulcer Treatment Market Summary

The global pressure ulcer treatment market size was estimated at USD 6.1 billion in 2025 and is projected to grow from USD 6.4 billion in 2026 to USD 9.8 billion by 2033, at a CAGR of 6.2% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 42.5% in 2025. The growth of the global market for pressure ulcer treatments is driven by the rising prevalence of pressure ulcers among elderly and immobile populations, increasing hospital and long-term care needs, greater adoption of advanced wound-care technologies, and growing emphasis on pressure ulcer prevention and standardized wound assessment.

The continued burden of pressure injuries is driving demand for effective treatment and wound-care solutions across hospitals and other healthcare settings. According to the 2025 AHRQ Network of Patient Safety Databases Chartbook, 93,807 pressure injury events were reported through December 2024. Among the 17,077 events with valid information on the most advanced stage, 66.6% (11,377 cases) were deep tissue pressure injuries, 10.2% (1,748 cases) were Stage 3, and approximately 21.1% (3,600 cases) were unstageable. The report also found that 77.1% of 17,936 reported events involved patients who had received a preventive intervention, indicating that pressure injuries continue to occur despite preventive measures. Furthermore, 63.8% of reported cases developed a secondary morbidity or had an unknown outcome, while Stage 4 injuries showed the highest reported harm rate at 82%. The substantial number of advanced and potentially harmful pressure injuries supports continued demand for advanced dressings, negative pressure wound therapy, pressure-relieving systems, and other treatment solutions.

In addition, the growing burden of pressure ulcers is driving demand for effective prevention, diagnosis, and treatment solutions, particularly among high-risk patients such as those with spinal cord injuries and limited mobility. The Spinal Injuries Association's Stop the Pressure Day 2025 highlighted the continuing impact of pressure ulcers in the UK. According to the initiative, more than 700,000 people are affected by pressure ulcers in the UK, with around 180,000 new cases diagnosed each year. The average treatment cost was reported at £11,703.54 per pressure ulcer per day (approximately USD 15,600), resulting in an estimated £22.4 million per day (approximately USD 29.9 million) in costs to the NHS. The initiative also highlighted gaps in care: among 761 people with spinal cord injuries surveyed in 2025, nearly 1 in 5 experienced a pressure ulcer during the previous year, while almost one-quarter reported that their pressure ulcer was not correctly diagnosed or treated. These findings highlight the substantial clinical and economic burden and support continued demand for pressure ulcer treatment and prevention solutions.

Manufacturers offer a diverse portfolio of pressure ulcer management products to address different levels of patient risk and wound severity. For instance, Novacare offers solutions such as dynamic mattress systems, hybrid mattresses, and advanced pressure - redistribution surfaces. Its portfolio includes ASX, ASX digital 6-inch, Smartline Hybrid, Smartline Pro, and APM 440 XC, designed for pressure ulcer prevention and management across diverse clinical needs.

Clinical trials landscape:

Clinical trials are supporting innovation in the market by generating evidence on the safety and effectiveness of advanced therapies for severe and difficult-to-treat wounds. Research is focused on treatments that can address infection, improve wound healing, reduce recurrence, and limit the need for systemic antibiotics. For instance, in February 2024, Biocomposites announced the launch of the Phase II BLADE-OPU2 clinical trial in the U.S. to evaluate the safety and efficacy of STIMULAN VG, a calcium matrix antibiotic carrier mixed with vancomycin and gentamicin, for the treatment of Stage IV pressure ulcers. The company reported that approximately 200,000 Stage IV pressure ulcer cases occur annually in the U.S. The trial is intended to evaluate whether localized antibiotic delivery can improve patient outcomes and reduce recurrent infections, highlighting the increasing development of advanced therapies for severe pressure ulcers.

Global Pressure Ulcer Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pressure ulcer treatment market report based on product, clinical severity, end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Wound Care Dressings
  • Moist
  • Foam Dressings
  • Hydrocolloid Dressings
  • Film Dressings
  • Alginate Dressings
  • Hydrogel Dressings
  • Collagen Dressings
  • Other Advanced Dressing
  • Antimicrobials
  • Silver
  • Non-silver
• Active & Bio-Therapies
  • Active Biomaterials
  • Bioengineered Skin Substitutes
  • Growth Factors
• Wound Care Devices & Systems
  • Negative Pressure Wound Therapy (NPWT)
  • Pressure Redistribution & Support Surfaces
  • Hyperbaric Oxygen Equipment
  • Electrical Stimulation Devices
• Topical & Pharmacological Agents
  • Debriding Agents
  • Topical Antimicrobials & Antiseptics
• Other Treatment Products
  • Offloading & Positioning Devices
  • Wound Cleansing & Irrigation Products
• Clinical Severity Outlook (Revenue, USD Billion, 2021 - 2033)
• Stage I
• Stage II
• Stage III
• Stage IV
• Deep Tissue Injury (DTI)
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Acute Care Hospital
• Long-term Acute Care Hospital
• Burn Center
• Ambulatory Surgery Center
• Hospital Outpatient Department Wound Care Clinic
• Inpatient Rehabilitation Facility
• Skilled Nursing Facility
• Long-term Care (living setting)
• Physician Office
• Home Healthcare
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Regional scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Pressure Ulcer Treatment Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising pressure ulcer prevalence
    • 3.2.1.2. Adoption of advanced wound care technologies
    • 3.2.1.3. Growing focus on standardized wound assessment
    • 3.2.1.4. Growing elderly population
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of advanced wound therapies
    • 3.2.2.2. Improved pressure ulcer prevention programs
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expansion of home-based wound care
    • 3.2.3.2. AI-enabled wound assessment
    • 3.2.3.3. Development of biological wound products
    • 3.2.3.4. Rising demand for medical device-related pressure injury solutions
    • 3.2.3.5. Integrated digital wound management
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Inconsistent pressure ulcer staging
    • 3.2.4.2. Limited clinical evidence for emerging therapies
• 3.3. Pressure Ulcer Treatment Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Pressure Ulcer Treatment Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Pressure Ulcer Treatment Market: Product Movement Analysis, 2025 & 2033 (USD Billion)
• 4.3. Global Pressure Ulcer Treatment Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
• 4.4. Wound Care Dressings
  • 4.4.1. Wound care dressings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.4.2. Moist
    • 4.4.2.1. Moist market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2.2. Foam Dressings
      • 4.4.2.2.1. Foam dressings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2.3. Hydrocolloid Dressings
      • 4.4.2.3.1. Hydrocolloid dressings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2.4. Film Dressings
      • 4.4.2.4.1. Film dressings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2.5. Alginate Dressings
      • 4.4.2.5.1. Alginate dressings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2.6. Hydrogel Dressings
      • 4.4.2.6.1. Hydrogel dressings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2.7. Collagen Dressings
      • 4.4.2.7.1. Collagen dressings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2.8. Other Advanced Dressing
      • 4.4.2.8.1. Other advanced dressing market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.4.3. Antimicrobials
    • 4.4.3.1. Antimicrobials market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.3.2. Silver
      • 4.4.3.2.1. Silver market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 4.4.3.3. Non-silver
      • 4.4.3.3.1. Non-silver market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.5. Active & Bio-Therapies
  • 4.5.1. Active & bio-therapies market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.5.2. Active Biomaterials
    • 4.5.2.1. Active biomaterials market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.5.3. Bioengineered Skin Substitutes
    • 4.5.3.1. Bioengineered skin substitutes market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.5.4. Growth Factors
    • 4.5.4.1. Growth factors market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.6. Wound Care Devices & Systems
  • 4.6.1. Wound care devices & systems market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.6.2. Negative Pressure Wound Therapy (NPWT)
    • 4.6.2.1. Negative pressure wound therapy (NPWT) market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.6.3. Pressure Redistribution & Support Surfaces
    • 4.6.3.1. Pressure redistribution & support surfaces market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.6.4. Hyperbaric Oxygen Equipment
    • 4.6.4.1. Hyperbaric oxygen equipment market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.6.5. Electrical Stimulation Devices
    • 4.6.5.1. Electrical stimulation devices market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.7. Topical & Pharmacological Agents
  • 4.7.1. Topical & pharmacological agents market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.7.2. Debriding Agents
    • 4.7.2.1. Debriding agents market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.7.3. Topical Antimicrobials & Antiseptics
    • 4.7.3.1. Topical antimicrobials & antiseptics market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.8. Other Treatment Products
  • 4.8.1. Other treatment products market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.8.2. Offloading & Positioning Devices
    • 4.8.2.1. Offloading & positioning devices market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.8.3. Wound Cleansing & Irrigation Products
    • 4.8.3.1. Wound cleansing & irrigation products market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Pressure Ulcer Treatment Market: Clinical Severity Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Pressure Ulcer Treatment Market: Clinical Severity Movement Analysis, 2025 & 2033 (USD Billion)
• 5.3. Global Pressure Ulcer Treatment Market Size & Trend Analysis, by Clinical Severity 2021 to 2033 (USD Billion)
• 5.4. Stage I
  • 5.4.1. Stage I market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.5. Stage II
  • 5.5.1. Stage II market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.6. Stage III
  • 5.6.1. Stage III market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.7. Stage IV
  • 5.7.1. Stage IV market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.8. Deep Tissue Injury (DTI)
  • 5.8.1. Deep tissue injury (DTI) market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Pressure Ulcer Treatment Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Pressure Ulcer Treatment Market: End Use Movement Analysis, 2025 & 2033 (USD Billion)
• 6.3. Global Pressure Ulcer Treatment Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
• 6.4. Acute Care Hospital
  • 6.4.1. Acute care hospital market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.5. Long-term Acute Care Hospital
  • 6.5.1. Long-term acute care hospital market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.6. Burn Center
  • 6.6.1. Burn center market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.7. Ambulatory Surgery Center
  • 6.7.1. Ambulatory surgery center market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.8. Hospital Outpatient Department Wound Care Clinic
  • 6.8.1. Hospital outpatient department wound care clinic market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.9. Inpatient Rehabilitation Facility
  • 6.9.1. Inpatient rehabilitation facility market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.10. Skilled Nursing Facility
  • 6.10.1. Skilled nursing facility market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.11. Long-term Care (living setting)
  • 6.11.1. Long-term care (living setting) market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.12. Physician Office
  • 6.12.1. Physician office market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.13. Home Healthcare
  • 6.13.1. Home healthcare market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Pressure Ulcer Treatment Market: Regional Estimates & Trend Analysis by Product, Clinical Severity, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.4. Europe
  • 7.4.1. Europe pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.6. Latin America
  • 7.6.1. Latin America pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Argentina pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.7. Middle East and Africa
  • 7.7.1. Middle East and Africa pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. South Africa pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Saudi Arabia pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. UAE pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait pressure ulcer treatment market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2025
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Technology Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. SYST'AM
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Ulcer Solutions, LLC.
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Stryker
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Baxter (Hillrom)
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Arjo
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. LINET
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Invacare Corporation
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. 3M
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Smith+Nephew
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. Molnlycke AB
    • 8.5.16.1. Company overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product Benchmarking
    • 8.5.16.4. Strategic initiatives
  • 8.5.17. Savaria
    • 8.5.17.1. Company overview
    • 8.5.17.2. Financial performance
    • 8.5.17.3. Product Benchmarking
    • 8.5.17.4. Strategic initiatives
  • 8.5.18. Joerns Healthcare
    • 8.5.18.1. Company overview
    • 8.5.18.2. Financial performance
    • 8.5.18.3. Product Benchmarking
    • 8.5.18.4. Strategic initiatives
  • 8.5.19. B. Braun SE
    • 8.5.19.1. Company overview
    • 8.5.19.2. Financial performance
    • 8.5.19.3. Product Benchmarking
    • 8.5.19.4. Strategic initiatives
  • 8.5.20. Medline
    • 8.5.20.1. Company overview
    • 8.5.20.2. Financial performance
    • 8.5.20.3. Product Benchmarking
    • 8.5.20.4. Strategic initiatives
  • 8.5.21. Convatec
    • 8.5.21.1. Company overview
    • 8.5.21.2. Financial performance
    • 8.5.21.3. Product Benchmarking
    • 8.5.21.4. Strategic initiatives
  • 8.5.22. ANZIAM BIO PRIVATE LIMITED
    • 8.5.22.1. Company overview
    • 8.5.22.2. Financial performance
    • 8.5.22.3. Product Benchmarking
    • 8.5.22.4. Strategic initiatives